ctrl K

Watchlist Price Alert

MBX Biosciences Inc. Comm... (MBX)

NASDAQ: MBX · Real-Time Price · USD

10.32

0.22 (2.18%)

At close: Jun 18, 2025, 1:51 PM

MBX Biosciences Common Stock Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	63K	111K	111K	111K	87K	39K	39K	39K
Gross Profit	-63K	-111K	-111K	-111K	-87K	-39K	-39K	-39K
Operating Income	-81.41M	-68.19M	-59.58M	-50.91M	-42.26M	-28.94M	-18.95M	-8.01M
Interest Income	5.29M	6.27M	4.4M	3.71M	3.31M	2.33M	1.18M	399K
Pretax Income	-73.47M	-61.92M	-55.18M	-47.2M	-38.95M	-26.61M	-17.77M	-7.61M
Net Income	-73.47M	-61.92M	-55.18M	-47.2M	-38.95M	-26.61M	-17.77M	-7.61M
Selling & General & Admin	12.57M	10.67M	9.54M	8.55M	7.85M	5.63M	3.37M	1.49M
Research & Development	68.77M	57.41M	49.92M	42.24M	34.32M	23.27M	15.55M	6.47M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	81.35M	68.08M	59.46M	50.8M	42.17M	28.9M	18.91M	7.97M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	21.79M	8.47M	-369K	-9.04M	-385K	12.93M	2.94M	-8.01M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	33.41M	33.39M	33.39M	33.38M	33.38M	31.85M	31.85M	33.38M
Shares Outstanding (Diluted)	33.41M	33.39M	33.39M	33.38M	33.38M	31.85M	31.85M	33.38M
EPS (Basic)	-4.44	-4.1	-3.63	-1.17	-0.92	-0.55	-0.55	-0.23
EPS (Diluted)	-4.44	-4.1	-3.63	-1.17	-0.92	-0.55	-0.55	-0.23
EBITDA	-80.66M	-66.42M	-54.82M	-46.19M	-37.97M	-25.68M	-18.47M	-7.57M
EBIT	-51.05M	-63.39M	-55.05M	-46.38M	-38.13M	-25.8M	-18.55M	-7.61M
Depreciation & Amortization	196K	244K	227K	192K	168K	120K	79K	39K